Circassia Pharmaceuticals plc is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company operates through three segments: Allergy, which relates to a range of immunotherapy development products for the treatment of allergy; NIOX, which relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO), and Respiratory, which relates to the portfolio of asthma and chronic obstructive pulmonary disease product candidates.
Ticker:
NIOX
ISIN:
GB00BJVD3B28
Address:
Northbrook House, Ro (click to copy or hover over here to view full address)
CSRHub includes data on risk management, ESG ratings, Environment Policy & Reporting, Energy & Climate Change, mutual funds investment, and Governance.